Biohaven (BHVN) Fuels Confidence With Encouraging Azetukalner Data [Yahoo! Finance]
Biohaven Ltd. Common Shares (BHVN)
Last biohaven ltd. common shares earnings: 2/25 04:45 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.biohavenpharma.com
Company Research
Source: Yahoo! Finance
On March 11, Ken Cacciatore from TD Cowen increased the price target on Biohaven Ltd. (NYSE:BHVN) from $15 to $30. The analyst maintained a Buy rating on the stock, which yields an adjusted upside potential of more than 258% at the prevailing level. Copyright: jezper / 123RF Stock Photo Since significant azetukalner data has now clearly validated the Kv7 MoA in focal epilepsy, the analyst has revised his model. He is also encouraged by the prospect of being able to promote the company based on its unique CNS AE profile, which is a positive factor leading up to the topline opakalim data expected mid-year. On March 10, Goldman Sachs maintained a Buy rating on Biohaven Ltd. (NYSE:BHVN). The firm increased its price target from $24 to $27. Goldman Sachs cited positive read-through from strong Phase 3 data reported by Xenon Pharmaceuticals, noting the results support confidence in the broader Kv7 class. The firm added that the data, along with potential premium pricing versus exis
Show less
Read more
Impact Snapshot
Event Time:
BHVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHVN alerts
High impacting Biohaven Ltd. Common Shares news events
Weekly update
A roundup of the hottest topics
BHVN
News
- Biohaven (BHVN) had its price target raised by Citigroup Inc. from $14.00 to $17.00. They now have a "buy" rating on the stock.MarketBeat
- Can Biohaven (BHVN) Redefine Obesity Treatment By Targeting Lean Mass Preservation With Taldefgrobep? [Yahoo! Finance]Yahoo! Finance
- Mixed signals cloud the orphan drug market [Yahoo! Finance]Yahoo! Finance
- Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential [Yahoo! Finance]Yahoo! Finance
- This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash [Yahoo! Finance]Yahoo! Finance
BHVN
Earnings
- 3/2/26 - Beat
BHVN
Sec Filings
- 3/19/26 - Form 4
- 3/13/26 - Form DEFA14A
- 3/13/26 - Form DEF
- BHVN's page on the SEC website